Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-COVID booster advice should come imminently, says UK minister

Sun, 28th Nov 2021 09:34

* UK wants to broaden booster campaign

* New measures are temporary

* Scotland also to introduce travel measures
(Adds Moderna's chief medical officer)

By Elizabeth Piper

LONDON, Nov 28 (Reuters) - Britain's health minister Sajid
Javid said on Sunday he expected to receive advice imminently on
whether the government can broaden a booster shot programme to
try to weaken the impact of the newly identified Omicron
coronavirus variant.

The government announced new measures on Saturday to try to
slow the spread of the variant, toughening rules for people
arriving into Britain and ordering the use of face masks in
retail settings and on transport in England.

But ministers also want to ramp up the offer of booster
jabs, saying even if vaccines prove to be less effective against
Omicron, they should offer better protection against it and
reduce the number of hospitalisations and deaths.

"The other thing that still remains hugely important, but I
think it's fair to say now more important than it was before, is
our vaccination programme," Javid told Sky News.

"That is why I have also asked our expert advisers on
vaccines called JCVI (the Joint Committee on Vaccination and
Immunisation) to give me very quick advice on broadening,
boosting our booster programme, and I expect to get that advice
imminently."

Earlier this month, Britain expanded eligibility for booster
jabs to people in their 40s and also said children aged 16 and
17 would be able to receive a second dose following guidance
from the JCVI.

Scotland, where the government sets its own rules for
health, already requires people to wear face coverings and work
from home if possible, but its first minister, Nicola Sturgeon,
told the BBC's Andrew Marr show she would also bring in new
rules for arrivals.

"I think we need to be open minded to doing anything
required to keep the population safe right now," she told the
BBC's Andrew Marr show.

The discovery of Omicron, dubbed a "variant of concern" last
week by the World Health Organization, has sparked worries
around the world https://www.reuters.com/world/new-coronavirus-variant-omicron-keeps-spreading-australia-detects-cases-2021-11-28
that it could resist vaccinations and prolong the nearly
two-year COVID-19 pandemic.

Britain has confirmed two cases of the new variant, and
Javid said the new measures were needed to buy time for experts
to try to understand more about Omicron, which may, or may not,
make vaccines less effective.

Paul Burton, chief medical officer at Moderna, said
if a new vaccine was needed to tackle the variant, "I think
that's going to be early 2022 before that’s really going to be
available in large quantities".

Javid repeated that it was not as yet clear whether vaccines
were less effective against the variant.

"The point is the vaccines are still going to give you more
protection than otherwise," he said. "That is why the booster
programme is so important."
(Reporting by Elizabeth Piper, Editing by Louise Heavens, Mark
Heinrich and Raissa Kasolowsky)

More News
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.